BS:HYPE3 Hypera S.A

Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under the Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, Apracur, Benegrip, Coristina d, Engov, Estomazil, Vitasay, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Agecare, Blancy, Dersab, Epidac, Epidrat, episol, Hidramamy, Lanidrat, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.This company has ADRs that trade in the U.S. as the symbol HYPMY.

42.80 BRL
As of 12/07/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  Brazil
Country of incorporation:  Brazil
IPO date:  04/18/2008
Stock exchange:    XBSP
Exchange country:   Brazil
Market cap:   23,319,408,640 BRL
Current dividend yield:   3.35%
Sedol:      B2QY968

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy